Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

NEP/ECE inhibitor SLV-306 reduces proteinuria and urinary albumin excretion in diabetic neuropathy

Nov. 11, 2004

Pramipexole for reducing excessive food intake

Nov. 11, 2004

GSK-3 inhibitors described by Pfizer researchers

Nov. 11, 2004

Ranbaxy patent claims metformin tablets for the treatment of diabetes

Nov. 10, 2004

Novel neutral endopeptidase inhibitors reported by Pfizer

Nov. 10, 2004

Preliminary findings for uterine fibroid study of Progenta

Nov. 10, 2004

Approval for new formulation of TriCor

Nov. 10, 2004

ARS scientists prepare and test novel amylin antiaggregatory peptides

Nov. 9, 2004

New PPARgamma activators and their use in type 2 diabetes and metabolic syndrome

Nov. 9, 2004

Improved visual acuity found with ruboxistaurin in DME involving the center of macula

Nov. 9, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
Genescience presents STAT6 degrader for atopic dermatitis
BioWorld Science
Genescience Pharmaceutical Co. Ltd. has presented data on a new STAT6 PROTAC degrader – GenSciP166 – which selectively targets STAT6 for proteasomal degradation....
Roche reports new TREM2 agonists
BioWorld Science
F. Hoffmann-la Roche Ltd. and Hoffmann-La Roche Inc. have identified new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for...